Fanconi Anemia (FA) is a rare, life-threatening genetic condition that leads to bone marrow failure and a high predisposition to various cancers. Historically, treatment was limited to supportive care and high-risk transplants. However, the modern market is shifting toward personalized medicine and regenerative therapies. The rising prevalence of blood-related genetic disorders and t... https://www.databridgemarketresearch.com/reports/global-fanconi-anemia-treatment-market